Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Nanotechnology Drug Delivery Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Nanotechnology Drug Delivery Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Nanotechnology Drug Delivery Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Nanotechnology Drug Delivery Market-Segmentation by Type
5.1 Nanocrystals
5.2 Nanoparticles
5.3 Liposomes
5.4 Micelles
5.5 Nanotubes
5.6 Others
6 Global Nanotechnology Drug Delivery Market-Segmentation by Application
6.1 Neurology
6.2 Oncology
6.3 Cardiovascular/Physiology
6.4 Anti-inflammatory/Immunology
6.5 Anti-infective
6.6 Others
7 Global Nanotechnology Drug Delivery Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Amgen
8.1.1 Amgen Profile
8.1.2 Amgen Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Amgen Product/Solution Launches and Enhancements Analysis
8.1.4 Amgen Business Overview/Recent Development/Acquisitions
8.2 Merck & Co
8.2.1 Merck & Co Profile
8.2.2 Merck & Co Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Merck & Co Product/Solution Launches and Enhancements Analysis
8.2.4 Merck & Co Business Overview/Recent Development/Acquisitions
8.3 Novartis International AG
8.3.1 Novartis International AG Profile
8.3.2 Novartis International AG Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Novartis International AG Product/Solution Launches and Enhancements Analysis
8.3.4 Novartis International AG Business Overview/Recent Development/Acquisitions
8.4 AbbVie
8.4.1 AbbVie Profile
8.4.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 AbbVie Product/Solution Launches and Enhancements Analysis
8.4.4 AbbVie Business Overview/Recent Development/Acquisitions
8.5 Bayer AG
8.5.1 Bayer AG Profile
8.5.2 Bayer AG Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Bayer AG Product/Solution Launches and Enhancements Analysis
8.5.4 Bayer AG Business Overview/Recent Development/Acquisitions
8.6 Celgene Corporation
8.6.1 Celgene Corporation Profile
8.6.2 Celgene Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Celgene Corporation Product/Solution Launches and Enhancements Analysis
8.6.4 Celgene Corporation Business Overview/Recent Development/Acquisitions
8.7 Pfizer
8.7.1 Pfizer Profile
8.7.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.7.4 Pfizer Business Overview/Recent Development/Acquisitions
8.8 Roche
8.8.1 Roche Profile
8.8.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Roche Product/Solution Launches and Enhancements Analysis
8.8.4 Roche Business Overview/Recent Development/Acquisitions
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Profile
8.9.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.9.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
9 Global Nanotechnology Drug Delivery Market-Segmentation by Geography
10 North America
10.1 North America Nanotechnology Drug Delivery Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Nanotechnology Drug Delivery Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Nanotechnology Drug Delivery Production Analysis from 2015-2020
10.4 North America Nanotechnology Drug Delivery Consumption Analysis from 2015-2020
10.5 North America Nanotechnology Drug Delivery Import and Export from 2015-2020
10.6 North America Nanotechnology Drug Delivery Value, Production and Market Share by Type (2015-2020)
10.7 North America Nanotechnology Drug Delivery Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Nanotechnology Drug Delivery by Country (United States, Canada)
10.8.1 North America Nanotechnology Drug Delivery Sales by Country (2015-2020)
10.8.2 North America Nanotechnology Drug Delivery Consumption Value by Country (2015-2020)
10.9 North America Nanotechnology Drug Delivery Market PEST Analysis
11 Europe
11.1 Europe Nanotechnology Drug Delivery Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Nanotechnology Drug Delivery Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Nanotechnology Drug Delivery Production Analysis from 2015-2020
11.4 Europe Nanotechnology Drug Delivery Consumption Analysis from 2015-2020
11.5 Europe Nanotechnology Drug Delivery Import and Export from 2015-2020
11.6 Europe Nanotechnology Drug Delivery Value, Production and Market Share by Type (2015-2020)
11.7 Europe Nanotechnology Drug Delivery Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Nanotechnology Drug Delivery by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Nanotechnology Drug Delivery Sales by Country (2015-2020)
11.8.2 Europe Nanotechnology Drug Delivery Consumption Value by Country (2015-2020)
11.9 Europe Nanotechnology Drug Delivery Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Nanotechnology Drug Delivery Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Nanotechnology Drug Delivery Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Nanotechnology Drug Delivery Production Analysis from 2015-2020
12.4 Asia-Pacific Nanotechnology Drug Delivery Consumption Analysis from 2015-2020
12.5 Asia-Pacific Nanotechnology Drug Delivery Import and Export from 2015-2020
12.6 Asia-Pacific Nanotechnology Drug Delivery Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Nanotechnology Drug Delivery Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Nanotechnology Drug Delivery by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Nanotechnology Drug Delivery Sales by Country (2015-2020)
12.8.2 Asia-Pacific Nanotechnology Drug Delivery Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Nanotechnology Drug Delivery Market PEST Analysis
13 Latin America
13.1 Latin America Nanotechnology Drug Delivery Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Nanotechnology Drug Delivery Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Nanotechnology Drug Delivery Production Analysis from 2015-2020
13.4 Latin America Nanotechnology Drug Delivery Consumption Analysis from 2015-2020
13.5 Latin America Nanotechnology Drug Delivery Import and Export from 2015-2020
13.6 Latin America Nanotechnology Drug Delivery Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Nanotechnology Drug Delivery Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Nanotechnology Drug Delivery by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Nanotechnology Drug Delivery Sales by Country (2015-2020)
13.8.2 Latin America Nanotechnology Drug Delivery Consumption Value by Country (2015-2020)
13.9 Latin America Nanotechnology Drug Delivery Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Nanotechnology Drug Delivery Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Nanotechnology Drug Delivery Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Nanotechnology Drug Delivery Production Analysis from 2015-2020
14.4 Middle East & Africa Nanotechnology Drug Delivery Consumption Analysis from 2015-2020
14.5 Middle East & Africa Nanotechnology Drug Delivery Import and Export from 2015-2020
14.6 Middle East & Africa Nanotechnology Drug Delivery Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Nanotechnology Drug Delivery Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Nanotechnology Drug Delivery by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Nanotechnology Drug Delivery Sales by Country (2015-2020)
14.8.2 Middle East & Africa Nanotechnology Drug Delivery Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Nanotechnology Drug Delivery Market PEST Analysis
15 Future Forecast of the Global Nanotechnology Drug Delivery Market from 2020-2028
15.1 Future Forecast of the Global Nanotechnology Drug Delivery Market from 2020-2028 Segment by Region
15.2 Global Nanotechnology Drug Delivery Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Nanotechnology Drug Delivery Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
